Novel inhibitors of the Plasmodium falciparum electron transport chain

  • Stocks P
  • Barton V
  • Antoine T
 et al. 
  • 28


    Mendeley users who have this article in their library.
  • 12


    Citations of this article.


Due to an increased need for new antimalarial chemotherapies that show potency against Plasmodium falciparum, researchers are targeting new processes within the parasite in an effort to circumvent or delay the onset of drug resistance. One such promising area for antimalarial drug development has been the parasite mitochondrial electron transport chain (ETC). Efforts have been focused on targeting key processes along the parasite ETC specifically the dihydroorotate dehydrogenase (DHOD) enzyme, the cytochrome bc 1 enzyme and the NADH type II oxidoreductase (PfNDH2) pathway. This review summarizes the most recent efforts in antimalarial drug development reported in the literature and describes the evolution of these compounds.

Author-supplied keywords

  • Antimalarial
  • dihydroorotate dehydrogenase
  • drug development
  • mitochondrial
  • structure-activity relationships

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • P. A. Stocks

  • V. Barton

  • T. Antoine

  • G. A. Biagini

  • S. A. Ward

  • P. M. O'neill

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free